GET THE APP

Neuromegen: Achieving rapid diagnosis for neurodevelopmental disorders
..

Molecular and Genetic Medicine

ISSN: 1747-0862

Open Access

Neuromegen: Achieving rapid diagnosis for neurodevelopmental disorders


Joint Event on 10th International Conference on Genomics and Molecular Biology & 6th International Conference on Integrative Biology

May 21-23, 2018 Barcelona, Spain

Ana Fernandez-Marmiesse

Unidad de Diagnostico y Tratamiento de Enfermedades Metabolicas Cong�©nitas, Hospital Cl�­nico Universitario de Santiago de Compostela, Spain

Scientific Tracks Abstracts: J Mol Genet Med

Abstract :

Diagnosis of neurodevelopmental diseases is significantly complicated by their variability of presentation. These disorders may present symptoms that could be erroneously attributed to a common disease, delaying diagnosis and ultimately contributing to reduced awareness. Technological advances in next generation sequencing (NGS) and target enrichment approaches have led to major changes in diagnostic workflows in this field. We discuss the milestones achieved with these developments, focusing on the results achieved for epileptic disorders. In a 4-year cohort study, a customized NGS-based panel (EPI-panel) was applied to the diagnostic workflow of over 215 infantile-onset epilepsy patients from Spain and Portugal. Simultaneous sequencing of 226 genes was performed using solution hybridization technology (Sure Select XT, Agilent) and subsequent sequencing using the MiSeq platform (Illumina). EPI-panel consists of (i) a custom panel design that is periodically updated with new disease-associated genes proposed in the literature; (ii) a variant-prioritization algorithm that takes into account specific population frequencies and mutation-susceptibility profiles for genes. We detected 98 variants in 50 different genes involved in neuronal excitability, neurodevelopment, synaptic transmission, metabolic pathways, and brain morphogenesis. An overall diagnostic yield of 40�50% was achieved. De novo mutations and CNVs constituted an important percentage of the genetic burden in the cases analyzed. The incorporation of the Neuromegen tools into the diagnostic protocol for these disorders shortens the time to diagnosis to 1�2 weeks, reduces the number of tests and treatments required, and can be used to orient genetic counseling. amarmiesse@gmail.com

Google Scholar citation report
Citations: 3919

Molecular and Genetic Medicine received 3919 citations as per Google Scholar report

Molecular and Genetic Medicine peer review process verified at publons

Indexed In

arrow_upward arrow_upward